Krka, d. d.
KRK
Classificação em ações
#2157
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Preço da ação
$313.05
Valor de mercado
$9.48B
Variação (1 dia)
-1.77%
Variação (1 ano)
35.37%
País
SI
Negociar Krka, d. d. (KRK)
Categoria
Healthcare
EPS de Krka, d. d. (KRK)
EPS em June 2026 TTM: $16.04
De acordo com os últimos relatórios financeiros e o preço das ações da Krka, d. d., o EPS atual da empresa (TTM) é $16.04. No final de 2023, a empresa teve um EPS de $11.21, uma diminuição em relação a ao EPS de 2022, que foi de $12.54.
Histórico de EPS da Krka, d. d. de 2010 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $16.04 | 32.86% |
| 2024 | $12.07 | 7.68% |
| 2023 | $11.21 | -10.61% |
| 2022 | $12.54 | 11.16% |
| 2021 | $11.28 | -0.08% |
| 2020 | $11.29 | 30.17% |
| 2019 | $8.67 | 38.23% |
| 2018 | $6.27 | 10.32% |
| 2017 | $5.69 | 61.36% |
| 2016 | $3.52 | -33.21% |
| 2015 | $5.28 | -13.98% |
| 2014 | $6.13 | -14.87% |
| 2013 | $7.21 | 13.81% |
| 2012 | $6.33 | 0.85% |
| 2011 | $6.28 | -7.19% |
| 2010 | $6.77 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -96.53% |
IN
|
